Author

Baoling Ying

Washington University in St. LouisORCID 0000-0002-9344-9004Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Synthetic Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Michael DiamondiD· 3 shared Darin K. EdwardsiD· 2 shared Jesse D. BloomiD· 2 shared Suzanne M. ScheafferiD· 2 shared Aaron J. SchmitziD· 1 shared Adam L. BaileyiD· 1 shared Adrianus C. M. BooniD· 1 shared Ajasja LjubetičiD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

Michael DiamondORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoprotein

Sameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, Wafaa B. Alsoussi, Tamarand L. Darling, Bernadeta Dadonaite, Alesandro Civljak, Stephen C. Horvath, Julian Q. Zhou, Wooseob Kim, Jackson S. Turner, Aaron J. Schmitz, Fangjie Han, Suzanne M. Scheaffer, Christopher W Farnsworth, , Ali H. Ellebedy

Booster SARS-CoV-2 mRNA vaccine recruits and broadens GC B cell responses targeting a highly conserved site on receptor binding domain of spike glycoprotein.

Science Immunology · Oct 10, 2025Peer-reviewedImmunology

Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain

Baoling Ying, Chieh-Yu Liang, Pritesh Desai, Suzanne M. Scheaffer, Sayda M. Elbashir, Darin K. Edwards, Larissa B. Thackray, Michael Diamond

This study shows that boosting mice with mRNA vaccines in the ipsilateral or contralateral arm leads to equivalent immune responses and protection against SARS-CoV-2 Omicron.

Journal of Virology · Aug 28, 2024Peer-reviewedMicrobiology

Multivalent designed proteins protect against SARS-CoV-2 variants of concern

Andrew C. Hunt, James Brett Case, Young‐Jun Park, Longxing Cao, Kejia Wu, Alexandra C. Walls, Zhuoming Liu, John E. Bowen, Andy Hsien-Wei Yeh, Shally Saini, Louisa Helms, Yan Ting Zhao, Tien-Ying Hsiang, Tyler N. Starr, Inna Goreshnik, , David A. Baker

The paper designs and characterizes trivalent miniprotein binders that neutralize SARS-CoV-2 variants with low pM IC50 values and provide prophylactic and therapeutic protection in mice.

Science Translational Medicine · Apr 12, 2022Peer-reviewedSynthetic Biology